logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11213528 B1

PDFFull Text
Date of Patent:
Jan. 04, 2022

Filed:

Mar. 02, 2020

Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile

Applicants:

Incyte Holdings Corporation, Wilmington, DE (US);

Incyte Corporation, Wilmington, DE (US);

Inventors:

Hui-Yin Li, Hockessin, DE (US);

James D. Rodgers, Landenberg, PA (US);

Assignees:

Incyte Holdings Corporation, Wilmington, DE (US);

Incyte Corporation, Wilmington, DE (US);

Attorneys:

Brian C. Trinque

Lathrop GPM LLP

Primary Examiner:

Susanna Moore

Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61P 17/12 (2006.01); A61P 17/06 (2006.01); A61P 17/08 (2006.01); C07D 487/04 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/0053 (2013.01); A61K 9/20 (2013.01); A61P 17/06 (2018.01); A61P 17/08 (2018.01); A61P 17/12 (2018.01); C07D 487/04 (2013.01); C07B 2200/07 (2013.01); C07B 2200/13 (2013.01);
Abstract

The present invention provides salt forms of (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile that are useful in the modulation of Janus kinase activity and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

Find Patent Forward Citations

Li, Hui-Yin. (2022). Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile (U.S. Patent No. 11213528). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11213528

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…